Related Experiment Videos

N-ethylmaleimide-modified heavy meromyosin. A probe for actomyosin interactions

Insights

Treatment with N-ethylmaleimide (NEM) modifies heavy meromyosin (HMM) to create a stable actin-HMM complex. This NEM-HMM inhibits muscle and amoeba contraction but not microtubule polymerization or ciliary beating.

Area of Science:

  • Biochemistry
  • Muscle Physiology
  • Cytoskeletal Dynamics

Background:

  • Heavy meromyosin (HMM) is a key component of the actomyosin contractile system.
  • Understanding HMM-actin interactions is crucial for elucidating muscle contraction mechanisms.

Purpose of the Study:

  • To investigate the effects of N-ethylmaleimide (NEM) on rabbit skeletal muscle HMM.
  • To characterize the functional consequences of NEM modification on HMM-actin binding and ATPase activity.

Main Methods:

  • Treatment of rabbit skeletal muscle HMM with the sulfhydryl reagent N-ethylmaleimide (NEM).
  • Analysis of NEM-HMM binding to actin using electron microscopy (arrowhead complexes).
  • Assays for actin-activated HMM-ATPase activity, actomyosin superprecipitation, and muscle/cytoplasmic strand contraction.

Main Results:

  • NEM treatment yields HMM (NEM-HMM) that binds tightly to actin, forming stable arrowhead complexes resistant to MgATP.
  • NEM-HMM inhibits actin activation of HMM-ATPase, actomyosin superprecipitation, and contraction of muscle myofibrils and amoeba cytoplasmic strands.
  • NEM-HMM does not affect in vitro microtubule polymerization or demembranated cilia beating.

Conclusions:

  • NEM modification of HMM disrupts its normal interaction with actin, leading to inhibition of contractile processes.
  • The results highlight the specific role of the modified site in actin-HMM interactions essential for muscle and cytoplasmic motility.
  • NEM-HMM serves as a valuable tool for studying the mechanics of actin-based motility, distinguishing it from microtubule-based processes.

Related Concept Videos